These patients also exhibited higher titres and prevalence of anti-SS-A antibodies (66.10 IU/mL (12.30, 240.00) vs 26.05 IU/mL (1.37, 240.00), p=0.192, 78.9% vs 52.8%, p=0.082), though these differences did not reach statistical significance ( online supplemental table 6 ).
← all excerpts
Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease.
1
—
—